Pep2Tango Therapeutics

About:

Pep2Tango Therapeutics is a biotechnology company that offers superior unimolecular multi-receptor drugs for obesity and related disorders.

Top Investors: Versant Ventures

Description:

Total Funding Amount:

$16.7M

Headquarters Location:

Potomac, Maryland, United States

Founded Date:

2021-01-01

Founders:

Cristina Rondinone

Number of Employees:

1-10

Last Funding Date:

2024-11-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai